Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana by Loïc Epelboin et al.
Epelboin et al. Malaria Journal 2012, 11:142
http://www.malariajournal.com/content/11/1/142RESEARCH Open AccessIs dengue and malaria co-infection more severe
than single infections? A retrospective
matched-pair study in French Guiana
Loïc Epelboin1,2,3*, Matthieu Hanf1,2, Philippe Dussart4, Sihem Ouar-Epelboin1, Félix Djossou2,5,
Mathieu Nacher1,2 and Bernard Carme1,2Abstract
Background: Dengue and malaria are two major arthropod-borne infections in tropical areas, but dual infections
were only described for the first time in 2005. Reports of these concomitant infections are scarce and there is no
evidence of more severe clinical and biological pictures than single infections.
Methods: To compare co-infections to dengue alone and malaria alone, a retrospective matched-pair study was
conducted between 2004 and 2010 among patients admitted in the emergency department of Cayenne hospital,
French Guiana.
Results: 104 dengue and malaria co-infection cases were identified during the study period and 208 individuals
were matched in two comparison groups: dengue alone and malaria alone. In bivariate analysis, co-infection clinical
picture was more severe than separated infections, in particular using the severe malaria WHO criteria. In
multivariate analysis, independent factors associated with co-infection versus dengue were: masculine gender, CRP
level> 50 mg/L, thrombocytopaenia< 50 109/L, and low haematocrit <36% and independent factors significantly
associated with co-infections versus malaria were red cells transfusion, low haematocrit< 36%,
thrombocytopaenia< 50 109/L and low Plasmodium parasitic load< 0.001%.
Conclusions: In the present study, dengue and malaria co-infection clinical picture seems to be more severe than
single infections in French Guiana, with a greater risk of deep thrombocytopaenia and anaemia.
Keywords: Dengue, Malaria, French Guiana, Thrombocytopaenia, Case–control studiesBackground
Dengue fever and malaria are the most common
arthropod-borne diseases in humans and represent
major public health problems. Dengue virus (family
Flaviridae, genus Flavivirus) and Plasmodium para-
sites are widespread in American and Asian tropical
regions and their endemic areas overlap extensively.
Nevertheless, reports of malaria and dengue dual in-
fection are scarce. Since the first case reported in
2005 [1], only case-reports and two descriptive studies
have been published. They have been reported with* Correspondence: epelboincrh@hotmail.fr
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reproduction in any medium, provided the orPlasmodium falciparum and/or Plasmodium vivax in
India and Pakistan [2-5], Southeast Asia [6,7], French
Guiana [8] and Brazil [9]. This phenomenon seems to be
uncommon. In a study performed in Thailand among 194
patients with dengue, no co-infection with malaria was
found [10], but in French Guiana, a retrospective study
performed in 2004–2005 on 1,723 consecutive febrile emer-
gency patients found 17 co-infections, including six acute
concurrent infections (e.g. 1% of dengue and 4% of malaria
cases) [8]. The influence of co-infections on severity is not
straightforward, therefore, the aim of this study was to
differentiate clinical and biological picture of co-infections
from infections alone and determine whether patients
infected by both malaria and dengue (MD) were more
severe than either infection alone (respectively M and D).l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Study location
French Guiana is a French Overseas territory located on
the north-eastern coast of South America. About 90% of
its surface of 84,000 km2 is Amazonian rain forest; the
remaining 10% in the north is a coastal plain where 90%
of the 215,000 inhabitants live and Cayenne and sur-
roundings contain almost 50% of the population in 2009
[11]. Malaria and dengue fever (DF) represent two major
public health concerns in French Guiana. Malaria is en-
demic and the annual number of cases ranges from
3,200 to 4,700 [12]. Until 2006, P. vivax represented 50%
of annual cases. The current proportion of P. vivax mal-
aria is 75%, as in the rest of the Americas [12-14]. Since
the first cases of DF were reported in French Guiana in
1943, an increase in the number of DF cases and DF out-
breaks and the emergence of dengue hemorrhagic fever
(DHF) have been observed [15]. All four dengue virus
serotypes circulate in French Guiana. The last two mains
epidemics occurred in 2006 and 2009, and dengue is cur-
rently endemic. Until 2005, dengue outbreaks were ex-
clusively described on the coast. Since 2006, outbreaks of
DF have been reported in interior villages where malaria
is endemic [16].
Study population
A matched retrospective study was conducted comparing
patients infected with concurrent malaria and dengue to
patients with either infection alone. The study popula-
tion included all patients admitted in the emergency de-
partment of Cayenne hospital, between June 2004 and
February 2010. The diagnosis of dengue and malaria co-
infection was made on the basis of concomitant bio-
logical diagnosis of dengue and malaria within seven
days in patients with a compatible clinical picture. Two
control groups were constituted: the group M with posi-
tive biological diagnosis for malaria and negative for den-
gue, according to the criteria defined in the next
paragraph, and the contrary for the group D. Control
cases were matched on the date of biological diagnosis
of infection.
Case definitions were based on compatible clinical his-
tory and biological diagnosis. Malaria diagnosis relied on
the identification of haematozoa on a thin blood film and/
or on a thick blood film stained with Giemsa (group MD
and M). The screening sensitivity was 6 plasmodia/μL
(1/1,000 leukocytes). The asexual parasite load (PL) was
classified in five classes: class 5: >1.25%; class 4: 0.125 to
1.25%; class 3 : 0.0125% to 0.125%; class 2: 0.00125 to
0.0125%; and class 1: ≤0.00125. Malaria rapid diagnosis
tests were not systematically performed on the study
period. Due to the evolution of the techniques between
2004 and 2010, the laboratory diagnosis of dengue relied
on different methods. Direct diagnosis was based on virusisolation, genome detection by Reverse Transcriptase-
Polymerase Chain Reaction (RT-PCR) or NS1 antigen de-
tection introduced in 2006 in French Guiana. Indirect
diagnosis was based on detection of specific anti-dengue
IgM and/or IgA antibodies in patients’ sera [17]. When
NS1 antigen detection was available, RT-PCR, which
allows serotype identification, was not systematically
performed.
Concerning dengue definition (groups MD and D),
cases were separated in two groups: “confirmed acute
dengue cases” (CADC) were defined by direct biological
diagnosis (NS1 antigen and/or RT-PCR and/or virus iso-
lation), IgM seroconversion (early serum sample negative
for IgM but convalescent sample positive) or IgA anti-
bodies detection. “Likely dengue cases” (LDC) were
defined by IgM antibodies detection. Indeed, IgM appear
between the 3rd and 5th day of fever but can persist for
over three months and IgA appear concomitantly with
IgM but does not persist longer than five to six weeks
[18,19]. There was no discrimination between dengue
primary infection and secondary infection, e.g., further
infection(s) by dengue of a different serotype.
Covariates included, data collection and statistical analysis
Patients’ data, including socio-epidemiologic data, previ-
ous medical history, clinical symptoms, and biological
results, were obtained from the computerized medical
charts. Data were analysed using R version 2.10.0W and
the EpicalcW package.
The continuous variables of interest were categorized
following the laboratory cut-off values, or published
values. They generally were dichotomized because of the
small sample size.
Two analyses were performed comparing separately
MD to D and MD to M. For categorical variables, a
matched bivariate analysis using the Wald test was per-
formed to identify factors associated with co-infections.
Statistical significance was set at p <0.05. Variables with
a p-value< 0.2 in bivariate analyses were entered into
multivariate model to identify the factors independently
associated with dengue-malaria co-infections. As bivari-
ate analysis were made in an exploratory way and used
as a selection criterion for inclusion in the final multi-
variate model (p< 0.20), we did not judge as a necessity
to adjust bivariate p-values for multiple comparisons.
Thus, bivariate p-values near to 0.05 must be relativized.
To obtain more powerful models, and because of the
missing data inherent to retrospective studies, variables
obtained from anamnesis and clinical examination and
variables with more than 5% of missing data were
excluded from the model. Thus, conditional multivariate
backward stepwise logistic regression estimated the
adjusted odds ratio (OR) and the confidence intervals
linked to co-infections.
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The retrospective use of anonymous patient files on the
site of patient care is authorized by the French National
Commission on Informatics and Liberties. All the data
collected retrospectively were anonymized in a standar-
dized case report form and in the database.
Results
Cases description
Between June 2004 and February 2010, 104 patients sat-
isfied the criteria for MD (Figure 1). Consequently, 208
patients were matched in each comparison group.
Among the 104 MD patients, 75 (72.1%) were men and
11 (10.6%) were 15 years-old or under. The mean age
was 33.8 years (range: 6 months to 83 years). Forty-one
(39.4%) were considered as CADC and 63 (60.6%) as
LDC versus 150 (72.1%) and 58 (27.9%; p <0.001) in the
group D, respectively (Table 1). The dengue virus sero-
type could be identified for only 10 (9.6%) of co-infected
patients (DENV-1: 3 (30%); DENV-2: 2 (20%) and
DENV-3: 5 (50%)) and 91 in the control group (DENV-1:
25 (27.5%); DENV-2: 25 (27.5%); DENV-3: 28 (30.8%) and
DENV-4: 13 (14.2%)). No significant difference was found
in the proportion of P. vivax between the MD group


































Dengue and malaria co-infectio
Figure 1 Monthly cases of malaria, dengue fever (curves) and dengue
department of Cayenne Hospital, French Guiana, between June 2004
Antilles-Guyane, Reference National Laboratory of Arboviruses and ParasitolP. falciparum (20.4% vs. 28%) and association of P. vivax
and P. falciparum (2.9% vs. 3.9%). Species identification
was not possible in two patients because they had received
anti-malarial treatment after positive rapid diagnostic
testing in a health centre. A low PL (class 1 and 2) tended
to be more frequent in the MD group than M group
(p 0.08) (Table 2).
Comparison of co-infection with dengue
Clinical and biological pictures of co-infection cases were
different from single infections and bivariate compari-
sons showed more differences between MD and D than
between MD and M (Table 3). MD patients were more
often adult men. A quarter of them reported having re-
cently visited the forest (military, forest workers or gold
miners) versus 3% in the D group. Patients from MD
group resided more frequently far from the coast than D
patients and had a history of malaria and recent malaria
attacks (<3 months). The duration of fever was longer in
MD patients and they were hospitalized more frequently
than D patients, but hospitalization was not longer.
More patients required a transfusion in the MD group.
The clinical presentation in MD patients was generally
more severe, with more fever above 40°C, tachycardia,










































n Dengue Malaria 
and malaria co-infection (columns) in the Emergency
and February 2010. Source : Institut de Veille Sanitaire - CIRE
ogy–Mycology Unit, Cayenne Hospital, French Guiana.
Table 1 Laboratory diagnosis of dengue infection in the
co-infected group and in the single dengue infection
group





Cell culture virus isolation and/or
RT-PCR*
9 (8.7) 56 (26.9) CADC}
NS1 antigen +/− IgM* 11 (10.6) 84 (40.4)
IgM+ IgA* 14 (13.5) 9 (4.3)
IgM seroconversion 7 (6.7) 1 (0.5)
IgM 63 (60.6) 58 (27.9) LDC}
Total 104 208
*RT-PCR Reverse transcriptase polymerase chain reaction, IgM Anti dengue
immunoglobulin M, IgA Anti dengue immunoglobulin A.
} CADC Confirmed acute dengue cases, LDC Likely dengue cases.
Table 2 Matched bivariate analysis between co-infected
patients and pure malaria infected patients





Males 75 (72.1) 162 (77.9) 0.26
Children (<15 years-old) 11 (10.6) 18 (8.7) 0.58
Journey in forest 26 (25) 51 (24.6) 0.96
Inhabitant of the coast¥ 86 (83.5) 151 (74.4) 0.11
Long admission (≥2 days) 43 (41.3) 72 (34.6) 0.25
Admission 37 (35.6) 69 (33.2) 0.67
Medical history of malaria 52 (50) 115 (62.8) 0.02}
Time since last malaria
attack< 90 days
19 (55.9) 49 (51.6) 0.91
Medical history of dengue 3 (3.4) 16 (9) 0.08}}
Duration of fever > 5 days 48 (48.5) 61 (29.9) 0.001}
Red cells transfusion 8 (7.7) 3 (1.4) 0.01}
Tachycardia (>90 bpm) 79 (79) 165 (82.1) 0.64
Hypotension (<90 mmHg) 10 (10.4) 7 (3.6) 0.01}
Fever≥40°C 15 (14.7) 24 (11.9) 0.47
Retro-orbital pain 4 (3.9) 10 (5) 0.61
Chills 36 (35.6) 64 (32.2) 0.7
Hemorrhagic signs 12 (11.5) 25 (12.4) 0.81
Shock signs 7 (6.8) 8 (4) 0.16}}
Rash 1 (1) 5 (2.5) 0.4
Nausea and / or vomiting 58 (56.9) 93 (45.8) 0.06}}
Neurological disorders 7 (6.8) 5 (2.5) 0.08}}
Dehydration 7 (7.4) 10 (5) 0.37
Mucocutaneous pallor 11 (11.6) 7 (3.5) 0.02}
Splenomegaly 9 (12.3) 23 (18.3) 0.08}
Mucocutaneous jaundice 9 (8.7) 9 (4.3) 0.14}}
ENT symptoms 6 (5.8) 10 (4.8) 0.72
Severe “malaria” cases†† 34 (32,7) 39 (18,7) 0,007
Low parasitaemia
(class<3)
20 (19.2) 24 (11.5) 0.08}}
Mildly low hemoglobin
(<12 g/dl)
37 (35.6) 43 (20.7) 0.05}}
Low hematocrit (<36%) 43 (41.3) 49 (23.6) 0.002}
Deep thrombocytopenia
(<50 G/L)
23 (22.1) 25 (12) 0.02}
Low prothrombin
(<70%)
14 (21.2) 22 (15.4) 0.33
Hyponatremia (<130) 7 (7.1) 15 (7.4) 0.87
Hypokalemia (<3) 6 (6.1) 15 (7.4) 0.67
Elevated creatinin
(>111 μmol/L)
4 (4) 14 (7) 0.29
Elevated bilirubin
(>50 μmol/L)
16 (16.8) 20 (10.5) 0.06
SGPT (>2 N) 10 (10.2) 33 (16.7) 0.16}
SGOT >2 N 13 (13.3) 23 (11.6) 0.66
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or more of the WHO clinical and/or biological criteria
for severe falciparum malaria [20] were more frequent in
the MD group than in the D group (p< 0.001). Increased
C - reactive protein (CRP), especially> 50 mg/L, was sig-
nificantly associated with MD co-infections (p <0.001)
relative to dengue alone. Retro-orbital pain, skin rash
and ENT symptoms were significantly associated with D.
Anaemia (p 0.02), severe thrombocytopaenia (p <0.001),
and elevated bilirubin (p <0.001) were more frequent in
MD patients. CADC diagnoses were significantly more
frequent in the D group than in the MD group. Anaemia,
severe thrombocytopaenia, male gender, high CRP level
and LDC diagnosis were significantly associated with co-
infection in multivariate analysis (Table 4).
Comparison of co-infection with malaria
No significant difference between MD and M was found
in terms of gender, age, place of residence and forest-
related activities (Table 2). A history of malaria was more
frequent in the M group. The fever duration was longer
in MD patients but not hospitalization. They received
significantly more transfusions (p 0.02). Low blood pres-
sure, signs of shock, pallor were significantly associated
with the MD group. Anaemia and severe thrombocyto-
paenia were also significantly more frequent in the MD
group. Cases which fulfilled one or more of the WHO
criteria for severe falciparum malaria [20] were more fre-
quent in the MD group than in the M group (p 0.007).
Anaemia, severe thrombocytopaenia, low parasitaemia,
and a high number of blood transfusions were independ-
ently associated with co-infections in multivariate ana-
lysis (Table 4).
Discussion
The unexceptional nature of the association of dengue
and malaria is confirmed in French Guiana. In regions
Table 2 Matched bivariate analysis between co-infected
patients and pure malaria infected patients (Continued)
CRP <5 2 (2) 1 (0.5) 0.22
CRP 5 à 50 29 (29) 78 (38) -
CRP>50 69 (69) 126 (61.5) -
* p calculated with Wald test in matched bivariate analysis.
} Significant p-values< 0.05.}}
p-values< 0.2 included in the matched multivariate model.
bpm Beats per minute.
¥ Inhabitants of the coast are defined as people living in Cayenne, Rémire-
Montjoly, Matoury Macouria, Kourou, Irakoubo or Mana.; Other people
declared to live in Cacao, Roura, Montsinnéry-Tonnégrande, Régina, Saül,
St-Elie, Saint Laurent du Maroni, Apatou, Maripasoula, Papaïchton, St George
de l’Oyapock, Camopi or Trois-Sauts. 4 people came from France, 1 from the
French Caribbean and 1 from French Polynesia.
†† WHO 2000 criteria for severe P. falciparum malaria
ENT Ear, Nose and Throat, SGPT Serum Glutamopyruvate Transferase, SGOT
Serum Glutamooxaloacetate Transférase, CRP C-reactive protein.
Table 3 Matched bivariate analysis between co-infected
patients and pure dengue infected patients
Results n (%) Co-infection
(n = 104)N (%)
Dengue
(n = 208)N (%)
p*
Males 75 (72.1) 119 (57.2) 0.01}
Children (<15 years-old) 11 (10.6) 49 (23.6) 0.008}
Journey in forest 26 (25) 7 (3.4) <0.001}
Living on the coast¥ 86 (83.5) 183 (92.9) 0.025}
Long admission (≥2 days) 43 (41.3) 71 (34.1) 0.23
Admission 37 (35.6) 45 (21.6) 0.01}
Medical history of malaria 52 (50) 21 (10.2) <0.001}
Time since last malaria
attack< 90 days
15 (44.1) 0 (0) -
Medical history of dengue 3 (3.4) 5 (2.7) 0.64
Duration of fever > 5 days 48 (48.5) 33 (16.3) <0.001}
Red cells transfusion 8 (7.7) 2 (1) 0.03}
Tachycardia (>90 bpm) 79 (79) 128 (64.6) 0.03}
Hypotension (<90 mmHg) 10 (10.4) 3 (1.8) 0.02}
Fever≥40°C 15 (14.7) 10 (4.9) 0.006}
Retro-orbital pain 4 (3.9) 26 (12.6) 0.01}
Chills 36 (35.6) 37 (18) 0.002}
Hemorrhagic signs† 12 (11.5) 32 (15.5) 0.31
Shock signs{ 7 (6.8) 5 (2.4) 0.06}}
Rash 1 (1) 30 (14.6) 0.007}
Neurological disorders 7 (6.8) 8 (3.9) 0.28
Nausea and / or vomiting 58 (56.9) 94 (45.6) 0.07}}
Dehydration 7 (7.4) 4 (1.9) 0.04}
Mucocutaneous pallor 11 (11.6) 3 (1.5) 0.003}
Splenomegaly 9 (12.3) 3 (3.1) 0.04}
Jaundice 9 (8.7) 6 (2.9) 0.03}
ENT symptoms 6 (5.8) 42 (20.2) 0.002}
Severe “malaria” cases†† 34 (32,7) 33 (15,9) <0,001
Confirmed acute
dengue cases
41 (39.4) 150 (72.1) <0.001}
Mildly low hemoglobin
(<12 g/dl)
37 (35.6) 40 (19.2) 0.002}
Low hematocrit (<36%) 43 (41.3) 34 (16.4) <0.001}
Deep thrombocytopenia
(<50 G/L)
23 (22.1) 6 (2.9) <0.001}
Low prothrombin (<70%) 14 (21.2) 19 (13.9) 0.18}}
Hyponatremia (<130) 7 (7.1) 5 (2.5) 0.08}}
Hypokalemia (<3) 6 (6.1) 3 (1.5) 0.04}
Elevated creatinin
(>111 μmol/L)
4 (4) 4 (2) 0.3
Elevated bilirubin
(>50 μmol/L)
16 (16.8) 3 (1.6) <0.001}
SGPT (>2 N) 10 (10.2) 32 (16) 0.2
SGOT >2 N 13 (13.3) 41 (20.5) 0.16}}
CRP <5 2 (2) 73 (35.3) <0.001}
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the classical concept that malaria occurs in rural areas
and dengue in urban areas may thus also be contradicted
by facts in many countries and simultaneous infections
may result from the overlap of the mosquito biotopes
[16].
This study presented some minor biases. There were a
higher number of cases based on the IgM detection in
the MD group than in the D group. Co-infected patients
with LDC were tested separately, so the association be-
tween MD and thrombocytopaenia, anaemia and fre-
quent transfusions persisted in bivariate analysis, but not
in multivariate analysis. However, when testing separately
all patients with CADC diagnosis, no significant differ-
ence was found in bivariate and multivariate analysis
which is probably due to the loss of power. The separ-
ation in two groups, LDC and CADC is arbitrary since
the decision to perform the direct diagnosis relied on
non verifiable information provided by patients on fever
duration, a relatively unreliable answer given the fre-
quent linguistic difficulties in FG. Studying confirmed
acute cases alone was questionable, and the authors
decided to study together likely and confirmed acute
cases because it allowed a larger sample. Furthermore,
associating likely cases would have minimized differences
between the group MD and malaria alone because “real”
associations would have been mixed with isolated mal-
aria cases. It appears that co-infected patients consulted
significantly later than the other groups, which may
explains the predominance of IgM-diagnosed cases.
However, almost all previous studies on dengue and mal-
aria co-infections relied on IgM diagnosis [1,2,4-8,21].
Another hypothesis to explain the relatively high number
of LDC in the study group is that malaria attack could
have been triggered by dengue infection, especially as
there is a majority of P. vivax infection, possibly relapses,
which are coherent with the high frequency of malaria
medical history, especially in the last three months in the
Table 3 Matched bivariate analysis between co-infected
patients and pure dengue infected patients (Continued)
CRP 5 à 50 29 (29) 115 (55.6) -
CRP>50 69 (69) 19 (9.2) -
* p calculated with Wald test in matched bivariate analysis.
} Significant p-values< 0.05.
}} p-values< 0.2 included in the matched multivariate model
bpm Beats per minute..
¥ People living on the coast are defined as people living in Cayenne,
Rémire-Montjoly, Matoury Macouria, Kourou, Irakoubo or Mana. ; Other people
declared to live in Cacao, Roura, Montsinnéry-Tonnégrande, Régina, Saül,
St-Elie, Saint Laurent du Maroni, Apatou, Maripasoula, Papaïchton, St George
de l’Oyapock, Camopi or Trois-Sauts. 4 people came from France, 1 from the
French Caribbean and 1 from French Polynesia.
†Hemorrhagic signs included purpura, gingival bleeding, epistaxis,
macroscopic hematuria, hematemesis, melena, rectal bleeding and hemoptysis.
{Signs of shock included systolic blood pressure <90 mmHg or not
responding to IV fluids and with or without oliguria. ENT symptoms included
diagnoses of rhinitis, nasopharyngitis, pharyngitis, sinusitis and otitis.
†† WHO 2000 criteria for severe P. falciparum malaria [20].
ENT Ear, Nose and Throat, SGPT Serum Glutamopyruvate Transferase, SGOT
Serum Glutamooxaloacetate Transférase, CRP C-reactive protein.
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quent in MD than in M group, another explanation
could be the discovery of asymptomatic P. vivax infec-
tions in patients living in endemic areas, but this
phenomenon has been barely described in the Amazon-
ian region in Amerindian population, which is not the
case here [23]. To ensure that low parasitaemia in the
co-infection group did not result from asymptomatic
infections, we tested MD patients with low parasitaemia
versus D separately. The association between MD and
thrombocytopaenia, anaemia, masculine gender, elevated
CRP level, frequent transfusions persisted in bivariate
analysis but not in multivariate analysis probably due to
the loss of power. This result suggests that they were




Co-infection versus dengue Confirmed acute dengue cases 5.3
Males 1.9
Low hematocrit (<36%) 4.3
Deep thrombocytopenia (<50. 109/L) 13.8
CRP 5 to 50 mg/L 5.0
CRP>50 mg/L 75.4
Co-infection versus malaria Red cells transfusion 7.3
Low hematocrit (<36%) 2.2
Deep thrombocytopenia (<50. 109/L) 2.2
Low parasitic load (class<3) 1.8
* Odds ratio (OR) and 95% confidence interval (95% CI) and p calculated by matche
** Odds ratio and 95% confidence interval and p calculated by matched multivariate
CRP C-reactive protein.The present study suggests an increased severity of the
simultaneous infection compared to the isolated infec-
tions, which has only been hypothesized previously [1,4],
in particular with haematological consequences. How-
ever, severe malaria cases as defined by the WHO were
more frequent in the MD group than in M and D separ-
ately in bivariate analysis [20]. Indeed because of insuffi-
cient power, P. vivax and P. falciparum malaria were
pooled, which limits the study of P. falciparum severe
malaria. Therefore, the biological influence of dengue
virus, which affects the endothelium, a major protagonist
of severe malaria pathophysiology, on the eventual sever-
ity of falciparum malaria, needs to be studied [24].
Co-infected patients presented deep thrombocytopenia
more frequently than patients with single infections. Low
platelets are common in dengue and malaria. In febrile
patients living or returning from endemic areas, it is a
good predictive factor of malaria [25,26] and in case of
negative malaria diagnosis it is a good predictive factor of
dengue [25]. During malaria attack in adults, thrombo-
cytopaenia is generally not considered to be a risk factor of
haemorrhage and increased mortality [27]. Nevertheless,
in non-immunized children with a malaria attack, a plate-
let count below 100 109/L has been demonstrated to be a
predictive factor of mortality [28]. Furthermore, a study
performed in France on 21,888 cases of imported P. falcip-
arum malaria showed that thrombocytopaenia below 50
109/L was associated with an increased risk of mortality
[29]. Considering dengue fever, high thrombocytopaenia is
a known severity criterion and is linked to a higher mortal-
ity [30]. In the present study, severe thrombocytopaenia
was not really accompanied with a recrudescence of haem-
orrhagic signs. No significant difference for the thrombo-
cytopaenia between P. vivax and P. falciparum wasfected group and single dengue infection and single
variate analysis Multivariate analysis Sensitivity
(%)
Specificity
(%)95% CI* p* OR** 95% CI** p**
2.9-9.7 <0.001 4.5 1.7-11.9 0.003 79.1 52.1
1.2-3.2 0.01 3.4 1.1-10.3 0.03 38.7 75.4
2.3-8.2 <0.001 8.4 2.2-32-5 0.002 53.5 74.3
4.1-46 <0.001 11.7 1.7-79.2 0.01 79.3 71.4
1.1-21.7 <0.001 5.3 0.9-29.3 0.06 - -
16-356.7 <0.001 74.4 12.2-453.3 <0.001 78.4 85.8
1.5-34.7 0.01 5.3 1.04-26.7 0.04 72.7 68.1
1.3-3.6 0.002 2 1.2-3.5 0.009 46.0 72.6
1.1-4.1 0.02 2.1 1.02-4.1 0.04 47.9 69.3
0.9-3.3 0.08 2.2 1.08-4.3 0.03 45.4 68.6
d bivariate analysis.
analysis.
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erally worsens linearly with the increase of PL. This rela-
tionship did not clearly appear in patients co-infected with
dengue so it is notable that deep thrombocytopaenia ap-
parently occurred even with low parasite loads when asso-
ciated with dengue virus.
Anaemia was more frequent in patients with dual
infection. There was a convergence of indirect signs,
such as pallor and transfusion need and elevated total
bilirubin, probably in relation to increased haemolysis.
Anaemia is a classical symptom of malaria but it is
barely described in dengue fever. Indeed, elevated
haematocrit is found in the severe dengue fever cases,
resulting in plasma leakage syndrome [30]. The study
performed on 21,888 cases of imported P. falciparum,
showed that haemoglobin< 8 g/dL was an independ-
ent predictive factor of mortality [29].
Conclusions
In the present study, concurrent dengue and malaria in-
fection tends to be more severe than single infections
notably for haematologic abnormalities, such as
thrombocytopaenia and anaemia, known risk factors of
severe dengue fever and/or malaria. However, whether
this increased severity results from longer evolution dur-
ation or increased virulence or both remains to be deter-
mined. The study was retrospective so the results should
be interpreted with caution. Whether prospective studies
with homogeneous biological diagnosis methods and pa-
tient groups would be necessary to confirm the greatest
severity of co-infection, the feasibility of such a study is
questionable because of the very low prevalence of dual
infection. The current evolution of these two mosquito-
borne infections suggests that co-infections could be-
come a medical problem. Since the biological and clinical
characteristics of dengue and malaria are very similar, all
clinicians treating patients in or returning from endemic
areas should systematically order examinations for both
diagnoses, even if one or the other is positive.
Abbreviations
95 CI: 95% Confidence interval; CADC: Confirmed acute dengue cases;
CRP: C-reactive protein; D: Dengue fever group; DF: Dengue fever;
DHF: Dengue haemorrhagic fever; ENT: Ear, nose and throat;
Ig: Immunoglobulin; IV: Intravenous; LDC: Likely dengue cases; M: Malaria
group; MD: Malaria and dengue co-infection group; OR: Odds ratio;
PL: Parasite load (PL); RT-PCR: Reverse transcriptase-polymerase chain reaction
(RT-PCR); SGOT: Serum glutamooxaloacetate transférase; SGPT: Serum
glutamopyruvate transferase; WHO: World health organization.
Competing interests
The authors declare no competing interests.
Acknowledgments
The authors thank Dr. Brigitte Moreau and Dr. Stephan Gonon, respectively
from the bacteriology laboratory and form the emergency department of
Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana and Luisiane
Carvalho, from the Institut de Veille Sanitaire, Cayenne, French Guiana for
their help in the acquisition of data.Author details
1CIC-EC Antilles Guyane CIE 802 Inserm, Centre Hospitalier Andrée Rosemon,
Cayenne, French Guiana. 2Research team EPaT EA 3593, University of French
West Indies and French Guiana, Cayenne, French Guiana. 3Service de
Maladies Infectieuses et Tropicales, Centre Hospitalier Pitié-Salpêtrière, 47–83
bd de l’Hôpital, 75013, Paris, France. 4Centre National de Référence des
Arboviroses, Institut Pasteur de Guyane, Cayenne, French Guiana. 5Infectious
and Tropical Diseases Department, Centre Hospitalier Andrée Rosemon,
Cayenne, French Guiana.
Authors’ contributions
LE participated in the design of the study, performed the statistical analysis,
contributed to the analysis and interpretation of data and drafted the
manuscript. MH performed the statistical analysis and contributed to the
analysis and interpretation of data. PD carried out the the immunoassays and
the RT-PCR, contributed to the analysis and interpretation of data and helped
to draft the manuscript SOE contributed to conception of the study and the
acquisition of data. FD conceived of the study and contributed to the
analysis and interpretation of data and helped to draft the manuscript. MN
conceived of the study and contributed to the analysis and interpretation of
data and helped to draft the manuscript. BC conceived the study and
contributed to the analysis and interpretation of data and helped to draft the
manuscript. All authors read and approved the final manuscript.
Received: 11 January 2012 Accepted: 1 May 2012
Published: 1 May 2012
References
1. Charrel RN, Brouqui P, Foucault C, de Lamballerie X: Concurrent dengue
and malaria. Emerg Infect Dis 2005, 11:1153–1154.
2. Arya CS, Mehta KL, Agarwal N, Agarwal BK, Mathai G, Moondhara A:
Episodes of concurrent dengue and malaria. Dengue Bulletin 2005,
29:208–209.
3. Deresinski S: Concurrent Plasmodium vivax malaria and dengue. Emerg
Infect Dis 1802, 2006:12.
4. Abbasi A, Butt N, Sheikh QH, Bhutto AR, Munir SM, Ahmed SM: Clinical
features, diagnostic techniques and management of dual dengue and
malaria infection. J Coll Physicians Surg Pak 2009, 19:25–29.
5. Ali N, Nadeem A, Anwar M, Tariq WU, Chotani RA: Dengue fever in malaria
endemic areas. J Coll Physicians Surg Pak 2006, 16:340–342.
6. Ward DI: A case of fatal Plasmodium falciparum malaria complicated by
acute dengue fever in East Timor. Am J Trop Med Hyg 2006, 75:182–185.
7. Thangaratham PS, Jeevan MK, Rajendran R, Samuel PP, Tyagi BK: Dual
infection by dengue virus and Plasmodium vivax in Alappuzha District,
Kerala, India. Jpn J Infect Dis 2006, 59:211–212.
8. Carme B, Matheus S, Donutil G, Raulin O, Nacher M, Morvan J: Concurrent
dengue and malaria in Cayenne Hospital, French Guiana. Emerg Infect Dis
2009, 15:668–671.
9. dos Santos Santana V, Lavezzo LC, Mondini A, Terzian AC, Bronzoni RV,
Rossit AR, Machado RL, Rahal P, Nogueira MC, Nogueira ML: Concurrent
Dengue and malaria in the Amazon region. Rev Soc Bras Med Trop 2010,
43:508–511.
10. Singhsilarak T, Phongtananant S, Jenjittikul M, Watt G, Tangpakdee N, Popak
N, Chalermrut K, Looareesuwan S: Possible acute coinfections in Thai
malaria patients. Southeast Asian J Trop Med Public Health 2006, 37:1–4.
11. Populations légales en vigueur à compter du 1er janvier 2010 - Guyane - 973.
[http://www.insee.fr].
12. Carme B: Substantial increase of malaria in inland areas of eastern French
Guiana. Trop Med Int Health 2005, 10:154–159.
13. Carme B, Ardillon V, Girod R, Grenier C, Joubert M, Djossou F, Ravachol F:
Situation épidémiologique du paludisme en Guyane. Med Trop (Mars)
2009, 69:19–25.
14. WHO: World Malaria Report. Geneva: World Health Organization; 2010:1–238.
15. Reynes JM: La dengue en Guyane Francaise. Historique et actualites. Bull
Soc Pathol Exot 1996, 89:98–100.
16. Meynard JB, Ardillon V, Venturin C, Ravachol F, Basurko C, Matheus S,
Gaborit P, Grenier C, Dussart P, Quenel P: First description of a dengue
fever outbreak in the interior of French Guiana, February 2006. Eur J
Public Health 2009, 19:183–188.
17. Dussart P, Petit L, Labeau B, Bremand L, Leduc A, Moua D, Matheus S, Baril L:
Evaluation of two new commercial tests for the diagnosis of acute
Epelboin et al. Malaria Journal 2012, 11:142 Page 8 of 8
http://www.malariajournal.com/content/11/1/142dengue virus infection using NS1 antigen detection in human serum.
PLoS Negl Trop Dis 2008, 2:e280.
18. Balmaseda A, Guzman MG, Hammond S, Robleto G, Flores C, Tellez Y, Videa
E, Saborio S, Perez L, Sandoval E, Rodriguez Y, Harris E: Diagnosis of dengue
virus infection by detection of specific immunoglobulin M (IgM) and IgA
antibodies in serum and saliva. Clin Diagn Lab Immunol 2003, 10:317–322.
19. Talarmin A, Labeau B, Lelarge J, Sarthou JL: Immunoglobulin A-specific
capture enzyme-linked immunosorbent assay for diagnosis of dengue
fever. J Clin Microbiol 1998, 36:1189–1192.
20. World Health Organization (WHO): Severe falciparum malaria. World
Health Organization, Communicable Diseases Cluster. Trans R Soc Trop
Med Hyg 2000, 94(Suppl 1):1–90.
21. Kaushik RM, Varma A, Kaushik R, Gaur KJ: Concurrent dengue and malaria
due to Plasmodium falciparum and P. vivax. Trans R Soc Trop Med Hyg
2007, 101:1048–1050.
22. Hanf M, Stephani A, Basurko C, Nacher M, Carme B: Determination of the
Plasmodium vivax relapse pattern in Camopi, French Guiana. Malar J
2009, 8:278.
23. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP: High
prevalence of asymptomatic Plasmodium vivax and Plasmodium
falciparum infections in native Amazonian populations. Am J Trop Med
Hyg 2002, 66:641–648.
24. Basu A, Chaturvedi UC: Vascular endothelium: the battlefield of dengue
viruses. FEMS Immunol Med Microbiol 2008, 53:287–299.
25. Carme B, Sobesky M, Biard MH, Cotellon P, Aznar C, Fontanella JM: Non-
specific alert system for dengue epidemic outbreaks in areas of endemic
malaria. A hospital-based evaluation in Cayenne (French Guiana).
Epidemiol Infect 2003, 130:93–100.
26. Ansart S, Perez L, Thellier M, Danis M, Bricaire F, Caumes E: Predictive
factors of imported malaria in 272 febrile returning travelers seen as
outpatients. J Travel Med 2010, 17:124–129.
27. WHO: Guidelines for the treatment of malaria. Secondth edition. Geneva:
World Health Organization Press; 2010:1–196.
28. Gerardin P, Rogier C, Ka AS, Jouvencel P, Brousse V, Imbert P: Prognostic
value of thrombocytopenia in African children with falciparum malaria.
Am J Trop Med Hyg 2002, 66:686–691.
29. Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M,
Fontanet A, Durand R: Risk factors for imported fatal Plasmodium
falciparum malaria, France, 1996–2003. Emerg Infect Dis 2007, 13:883–888.
30. WHO: Dengue: guidelines for diagnosis, treatment, prevention and
control. In World Health Organization and the Special Programme for
Research and Training in Tropical Diseases (TDR). Geneva 2009:160.
doi:10.1186/1475-2875-11-142
Cite this article as: Epelboin et al.: Is dengue and malaria co-infection
more severe than single infections? A retrospective matched-pair
study in French Guiana. Malaria Journal 2012 11:142.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
